Your browser doesn't support javascript.
loading
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.
Ascierto, Paolo Antonio; Orlova, Kristina; Grignani, Giovanni; Dudzisz-Sledz, Monika; Fenig, Eyal; Chiarion Sileni, Vanna; Fazio, Nicola; Samimi, Mahtab; Mortier, Laurent; Gebhardt, Christoffer; Kramkimel, Nora; Steven, Neil; Bechter, Oliver; Arance, Ana; Benincasa, Elena; Kostkova, Lenka; Costa, Nuno; Lorigan, Paul.
Afiliación
  • Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
  • Orlova K; FSBI "N.N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
  • Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Dudzisz-Sledz M; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Fenig E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Chiarion Sileni V; Istituto Oncologico Veneto - IOV IRCCS, Padova, Italy.
  • Fazio N; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
  • Samimi M; Dermatology Department, University Hospital of Tours, Tours, France.
  • Mortier L; Dermatology Clinic, CARADERM and University of Lille, INSERM U1189, Lille Hospital-Claude Huriez Hospital, Lille Cedex, France.
  • Gebhardt C; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Kramkimel N; Department of Dermatology, Hôpital Cochin, AP-HP, Paris, France.
  • Steven N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Bechter O; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Arance A; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Benincasa E; The healthcare business of Merck KGaA, Darmstadt, Germany.
  • Kostkova L; Merck spol. s r.o., Bratislava, Slovakia, an affiliate of Merck KGaA, Darmstadt, Germany.
  • Costa N; Pfizer Inc., Porto Salvo, Portugal.
  • Lorigan P; Division of Cancer Sciences, University of Manchester and the Christie NHS Foundation Trust, Manchester, UK.
Int J Cancer ; 149(11): 1926-1934, 2021 12 01.
Article en En | MEDLINE | ID: mdl-34310716
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia / Europa Idioma: En Revista: Int J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia / Europa Idioma: En Revista: Int J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Italia